VeriMomtrigonella foenum-graecum seed extract hamilelikte güvenli mi?
No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
Pregnancy-safe products containing trigonella foenum-graecum seed extract
Related ingredients
Frequently asked questions
- trigonella foenum-graecum seed extract hamilelikte güvenli mi?
- No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
- trigonella foenum-graecum seed extract emzirirken güvenli mi?
- No regulatory ban or harmonised lactation hazard was identified. Clinical reviews note fenugreek has been used as an oral galactagogue and that safety data in nursing mothers/infants are limited and mixed; this is an oral systemic context, not topical cosmetic use. There is no authoritative CIR or SCCS safety opinion flagging breastfeeding risk for the cosmetic extract. (PubMed review; ECHA/COSING).
- trigonella foenum-graecum seed extract bebek cildi için güvenli mi?
- No evidence of specific developmental or infant dermal toxicity was found and no regulatory restriction for use on infant skin was located. However, infant skin has higher permeability; for a botanical extract with measurable constituents, exposure via leave‑on topical use can be higher in babies — therefore exposure score is increased by +1 for 0–3 yr. No infant‑specific studies demonstrating placental/dermal transfer or endocrine disruption were found. (PubMed; COSING).
- VeriMom trigonella foenum-graecum seed extract nasıl puanlıyor?
- VeriMom trigonella foenum-graecum seed extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte trigonella foenum-graecum seed extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.